March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Leveraging the Defense Innovation Ecosystem for Maximum Effect
Commentary
Introduction At a moment when the resilience of the wartime acquisition system is a national priority, start-ups, primes, investors, and the U.S. government must align to turn...
By Aaron Peterman & Sohaila Mali
-
Markets React as Trump Orders Military Action in Hormuz
Video
President Trump orders the U.S. military to target any boat laying mines in the Strait of Hormuz, escalating tensions with Iran and sending oil prices sharply higher. Bloomber...
By Becca Wasser
-
Trump: U.S. Will Work with Iran to Get Its "Nuclear Dust"
Video
Becca Wasser, adjunct senior fellow at the Center for a New American Security joins CNN to discuss the nuclear situation in Iran.Watch the full interview on CNN....
By Becca Wasser
-
Iran: No Plan for Talks After U.S. Seizes Ship
Video
Becca Wasser, adjunct senior fellow at the Center for a New American Security, joins CNN to discuss the U.S. blockade.Watch the full interview on CNN....
By Becca Wasser
